BeStock  

DaVita DVA

US equityMarket cap rank #1404Medical Care Facilities
$161.03 +$4.69 (+3.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $161.03 0.00%
Open$157.86
Prev close$156.34
Day range$157.20 – $162.99
Volume730.2K
Market cap$10.13B
P/E (TTM)11.9
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$3.58B+4.6% YoY
Operating profit$553.19M+11.6% YoY
Net profit$269.39M+12.1% YoY
Diluted EPS$3.40+66.7% YoY
Free cash flow$359.34M-46.8% YoY
Operating cash flow$518.83M

Revenue, last 8 quarters

$3.3BDec '24$3.2BMar '25$3.4BJun '25$3.4BSep '25$3.6BDec '25$3.4BMar '26$3.6BJun '26$3.6BSep '26

Net profit, last 8 quarters

$349.2MDec '24$232.2MMar '25$275.2MJun '25$240.2MSep '25$331.0MDec '25$275.0MMar '26$343.2MJun '26$269.4MSep '26

Diluted EPS by quarter

3.09Dec '242.00Mar '252.58Jun '252.04Sep '253.29Dec '252.87Mar '264.02Jun '263.40Sep '26

Free cash flow by quarter

$377.0MDec '24$36.8MMar '25$203.1MJun '25$675.4MSep '25$395.3MDec '25$218.8MMar '26$320.3MJun '26$359.3MSep '26

Annual revenue

$11.6BFY20$11.6BFY21$11.6BFY22$12.1BFY23$12.8BFY24$13.6BFY25

Profitability & balance sheet

Gross margin32.3%
Operating margin15.2%
Net margin6.5%
Return on assets5.2%
Current ratio1.41
Liabilities / assets93.7%
Cash & investments$566.30M
Total debt$12.95B
Net cash (debt)-$12.39B
Free cash flow / sales9.1%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • United States (US) dialysis$3.05B 84.7%
  • Other - Ancillary services$551.77M 15.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $3.58B $3.55B $3.42B $13.64B $3.62B
Total Operating Revenue $3.58B $3.55B $3.42B $13.64B $3.62B
Cost of Revenue $2.45B $2.39B $2.34B $9.24B $2.41B
Gross Profit $1.13B $1.16B $1.07B $4.40B $1.21B
Operating Expense $573.89M $591.27M $599.74M $2.39B $659.07M
Selling and Admin Expenses $408.70M $423.46M $421.91M $1.67B $472.36M
-General & Admin Expense $408.70M $423.46M $421.91M $1.67B $472.36M
Depreciation & Amortization & Depletion $165.19M $167.81M $177.83M $715.35M $186.70M
-Depreciation & Amortization $165.19M $167.81M $177.83M $715.35M $186.70M
Operating Profit $553.19M $570.82M $473.55M $2.01B $551.21M
Net Non-Operating Interest Income (Expense) -$150.02M -$150.26M -$145.13M -$579.93M -$148.25M
Non-Operating Interest Expense $150.02M $150.26M $145.13M $579.93M $148.25M
Other Income (Expense) -$44.47M $14.45M $12.82M -$83.87M -$20.19M
Earnings from Equity Interest $8.24M $8.18M $8.34M $33.00M $9.87M
Special Income (Charges) -$62.18M -$2.04M – -$14.18M -$9.03M
-Less:Impairment of Capital Assets $62.18M – – $0.00 $0.00
Other Non-Operating Income (Expenses) $9.47M $8.30M $4.47M -$102.69M -$21.03M
Pretax Profit $358.71M $435.01M $341.23M $1.35B $382.76M
Tax $89.32M $91.79M $66.20M $293.11M $76.73M
Net Profit $269.39M $343.22M $275.04M $1.08B $331.03M
Profit from Continuing Operations $269.39M $343.22M $275.04M $1.05B $306.03M
Minority Interests $46.46M $77.83M $77.51M $331.91M $96.81M
Net Income to Parent Company $222.93M $265.40M $197.53M $746.80M $234.22M
Net Income to Common Stockholders $222.93M $265.40M $197.53M $746.80M $234.22M
Basic EPS $3.49 $4.10 $2.93 $10.06 $3.36
Diluted EPS $3.40 $4.02 $2.87 $9.84 $3.29
-Less:Other Special Charges – $2.04M – $14.18M $9.03M
-Less:Restructuring and Mergern & Acquisition – – – $0.00 –
Net Income from Discontinuous Operations – – – $25.00M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $17.82B $17.71B $17.50B $17.48B $17.48B
Total Current Assets $4.07B $4.19B $4.06B $4.06B $4.06B
Cash and Cash Equivalents & Short-Term Investments $566.30M $688.88M $666.55M $700.74M $700.74M
-Cash and Cash Equivalents $495.63M $668.96M $644.24M $676.44M $676.44M
-Short Term Investments $70.67M $19.91M $22.30M $24.30M $24.30M
Receivables $3.12B $3.12B $3.01B $2.96B $2.96B
-Accounts Receivable $2.51B $2.47B $2.46B $2.41B $2.41B
-Taxes Receivable $47.81M $84.60M $35.78M $49.94M $49.94M
-Other Receivables $565.46M $565.57M $517.65M $494.41M $494.41M
Inventory $161.46M $151.54M $141.61M $160.63M $160.63M
Restricted Cash $83.63M $82.90M $82.16M $81.31M $81.31M
Other Current Assets $141.15M $149.11M $159.58M $156.29M $156.29M
Total Non-Current Assets $13.74B $13.52B $13.44B $13.42B $13.42B
Net PPE $5.17B $5.18B $5.15B $5.21B $5.21B
-Gross PPE $12.15B $12.05B $11.90B $11.81B $11.81B
-Accumulated Depreciation -$6.99B -$6.87B -$6.75B -$6.60B -$6.60B
Investments and Advances $442.69M $222.17M $206.91M $198.22M $198.22M
-Available for Sale Securities $38.38M $38.37M $34.96M $36.55M $36.55M
-Held to Maturity Securities $0.00 $0.00 $4.51M $4.42M $4.42M
-Long Term Equity Investment $404.31M $183.80M $167.44M $157.25M $157.25M
Goodwill and Other Intangible Assets $7.77B $7.82B $7.81B $7.77B $7.77B
-Goodwill $7.55B $7.59B $7.58B $7.55B $7.55B
-Other Intangible Assets $221.07M $228.82M $229.02M $222.13M $222.13M
Other Non-Current Assets $364.51M $298.54M $266.99M $246.52M $246.52M
Total Liabilities $16.69B $16.63B $16.45B $16.32B $16.32B
Total Current Liabilities $2.89B $2.86B $2.87B $3.14B $3.14B
Payables $740.06M $777.01M $815.17M $982.13M $982.13M
-Accounts Payable $662.20M $715.87M $691.26M $696.15M $696.15M
-Total Tax Payable $23.14M $24.62M $37.42M $86.04M $86.04M
-Due to Related Parties Current $54.71M $36.51M $86.50M $199.94M $199.94M
Short-Term Debt and Capital Lease Obligation $550.62M $556.67M $544.87M $534.69M $534.69M
-Current Debt $112.49M $117.18M $112.65M $109.20M $109.20M
-Current Capital Lease Obligation $438.13M $439.49M $432.22M $425.48M $425.48M
Other Current Liabilities $848.18M $827.00M $799.38M $642.29M $642.29M
Total Non-Current Liabilities $13.80B $13.77B $13.58B $13.18B $13.18B
Long Term Debt and Capital Lease Obligation $12.84B $12.85B $12.68B $12.34B $12.34B
-Long Term Debt $10.66B $10.66B $10.51B $10.16B $10.16B
-Long Term Capital Lease Obligation $2.19B $2.19B $2.16B $2.18B $2.18B
Non-Current Deferred Liabilities $861.69M $825.72M $818.92M $756.87M $756.87M
Other Non-Current Liabilities $100.43M $99.09M $88.85M $83.52M $83.52M
Total Equity $1.13B $1.08B $1.05B $1.16B $1.16B
Stockholders' Equity -$591.09M -$765.10M -$755.50M -$651.08M -$651.08M
Capital Stock $69,000.00 $69,000.00 $69,000.00 $69,000.00 $69,000.00
-Common Stock $69,000.00 $69,000.00 $69,000.00 $69,000.00 $69,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $53.98M $0.00 $0.00 $0.00 $0.00
Retained Earnings $301.57M $81.23M -$179.24M -$328.43M -$328.43M
Less: Treasury Stock -$917.24M -$787.85M -$489.36M -$199.94M -$199.94M
Gains/Losses Not Affecting Retained Earnings -$29.46M -$58.55M -$86.96M -$122.78M -$122.78M
Minority Interests $1.72B $1.84B $1.80B $1.81B $1.81B
Current Accrued Expenses – – – $189.05M $189.05M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $518.83M $490.07M $320.83M $1.89B $540.73M
Net cash flow from continuing operations $518.83M $490.07M $320.83M $1.89B $540.73M
Net Income from Continuing Operations $269.39M $343.22M $275.04M $1.08B $331.03M
Gain/Loss from Continuing Operations -$1.55M $2.47M -$30,000.00 $146.70M $50.91M
Depreciation & Depletion & Amortization $165.19M $167.81M $177.83M $715.35M $186.70M
Deferred Tax $37.78M -$1.37M $54.80M $86.57M $17.59M
Other Non-Cash Items -$2.05M $10.02M $6.71M -$17.55M -$29.07M
Change in Working Capital -$41.29M -$58.11M -$221.67M -$263.24M -$54.83M
-Change in Receivables -$43.39M $5.55M -$29.75M -$210.63M -$65.94M
-Change in Inventory -$10.21M -$8.96M $20.28M -$19.95M -$20.86M
-Change in Payables and Accrued Expense $52.88M $11.43M -$112.12M $128.30M $30.42M
-Change in Other Current Assets -$16.80M -$55.80M -$25.34M -$164.55M -$11.10M
-Change in Other Current Liabilities $7.92M $49.32M -$101.86M -$22.62M -$24.91M
-Change In Other Working Capital -$31.69M -$59.66M $27.13M $26.20M $37.56M
Net cash flow from investing -$420.11M -$194.25M -$139.09M -$654.95M -$163.13M
Net Cash Flow from Continuing Investing Activities -$420.11M -$194.25M -$139.09M -$654.95M -$163.13M
Net PPE Purchase and Sale -$159.49M -$169.82M -$102.02M -$575.86M -$145.43M
Net Business Purchase and Sale -$205.37M -$21.93M -$36.23M -$144.50M -$23.70M
Net Investment Purchase and Sale -$67.38M -$3.17M -$4.67M $29.70M $4.14M
Net Other Investing Changes $11.91M $671,000.00 $3.72M $34.17M $1.84M
Financing Cash Flow -$271.13M -$270.19M -$213.34M -$1.37B -$414.52M
Net Cash Flow from Continuing Financing Activities -$271.13M -$270.19M -$213.34M -$1.37B -$414.52M
Net Issuance Payments Of Debt -$13.58M $157.81M $346.09M $823.44M $31.99M
Net Common Stock Issuance -$109.52M -$364.35M -$396.31M -$1.79B -$328.83M
Proceeds from Stock Option Exercised $8.60M $3.52M $2.39M $23.29M $5.71M
Net Other Financing Charges -$156.63M -$67.17M -$165.51M -$428.51M -$123.39M
Ending Cash Balance $579.26M $751.86M $726.40M $757.75M $757.75M
Net Change in Cash -$172.41M $25.63M -$31.60M -$143.23M -$36.92M
Beginning Cash Balance $751.86M $726.40M $757.75M $879.83M $795.41M
Effect of Exchange Rate Changes -$189,000.00 -$179,000.00 $259,000.00 $21.15M -$746,000.00
Free Cash Flow $359.34M $320.25M $218.81M $1.31B $395.30M

Discussion

No comments yet — be the first to weigh in on DVA.

Sign in to join the discussion.

Scroll to Top